Mouze Liu

467 total citations
15 papers, 331 citations indexed

About

Mouze Liu is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mouze Liu has authored 15 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mouze Liu's work include Renal Transplantation Outcomes and Treatments (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Mouze Liu is often cited by papers focused on Renal Transplantation Outcomes and Treatments (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Mouze Liu collaborates with scholars based in China. Mouze Liu's co-authors include Yingzi Ming, Wei Zhang, Yu Meng, Jian‐Quan Luo, Zhiying Luo, Wenhui Liu, Pingfei Fang, Huan Ren, Daxiong Xiang and Ying Wang and has published in prestigious journals such as Frontiers in Immunology, Life Sciences and Frontiers in Pharmacology.

In The Last Decade

Mouze Liu

15 papers receiving 329 citations

Peers

Countries citing papers authored by Mouze Liu

Since Specialization

Citations

This map shows the geographic impact of Mouze Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mouze Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mouze Liu more than expected).

Fields of papers citing papers by Mouze Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mouze Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mouze Liu. The network helps show where Mouze Liu may publish in the future.

Co-authorship network of co-authors of Mouze Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Mouze Liu. A scholar is included among the top collaborators of Mouze Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mouze Liu. Mouze Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Unveiling the role of FTO polymorphisms in predicting response to immune checkpoint inhibitors: A retrospective study 2024 ·International Immunopharmacology ·Wenhui Liu, (unknown), Jian‐Quan Luo, Mouze Liu, Bao Sun, (unknown)	2
2	Integration of genomics, clinical characteristics and baseline biological profiles to predict the risk of liver injury induced by high-dose methotrexate 2024 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), Bikui Zhang, Ting Cao, (unknown), Hui Chen, Yifang He, Mouze Liu, Hualin Cai	1
3	Integrated analysis of clinical and genetic factors on the interindividual variation of warfarin anticoagulation efficacy in clinical practice 2023 ·BMC Cardiovascular Disorders ·(unknown), (unknown), (unknown), Jian‐Quan Luo, Mouze Liu, Wenhui Liu, Zhiying Luo	1
4	Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors 2021 ·Frontiers in Immunology ·Wenhui Liu, Ying Wang, Jian‐Quan Luo, Mouze Liu, Zhiying Luo	33
5	Peripheral Blood Markers Associated with Immune-Related Adverse Effects in Patients Who Had Advanced Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors 2021 ·Cancer Management and Research ·Wenhui Liu, Yiping Liu, Fang Ma, Bao Sun, Ying Wang, Jian‐Quan Luo, Mouze Liu, Zhiying Luo	33
6	Prognostic value of liver and kidney function parameters and their correlation with the ratio of urine‐to‐plasma paraquat in patients with paraquat poisoning 2021 ·Basic & Clinical Pharmacology & Toxicology ·Shuangyang Zhang, (unknown), Xuemei Luo, Jianfeng Liu, Mouze Liu, Wenqun Li, Ting Cao, Nana Li, (unknown), Bikui Zhang, Hualin Cai	18
7	TRIB3 rs6037475 is a potential biomarker for predicting felodipine drug response in Chinese patients with hypertension 2020 ·Annals of Translational Medicine ·Fazhong He, Bao Sun, Ling Li, Mouze Liu, Weijie Lin, (unknown), (unknown), (unknown), Lin Wu, Ligong Lu, Wei Zhang, Zhiling Zhou	7
8	Slow-Release H2S Donor Anethole Dithiolethione Protects Liver From Lipotoxicity by Improving Fatty Acid Metabolism 2020 ·Frontiers in Pharmacology ·Chengcheng Zhao, (unknown), Wenqun Li, Hualin Cai, Mouze Liu, Yanjie Hu, Yiping Liu, Mimi Tang	7
9	Incorporation of Gene‐Environment Interaction Terms Improved the Predictive Accuracy of Tacrolimus Stable Dose Algorithms in Chinese Adult Renal Transplant Recipients 2019 ·The Journal of Clinical Pharmacology ·Jie Tang, Jing Xu, (unknown), Rong Liu, Mouze Liu, HU Yong-fang, Mingjie Shao, Li‐Jun Zhu, Shan Cao, Hua‐Wen Xin, Guiwen Feng, Wenjun Shang, Xiang‐Gao Meng, Lirong Zhang, Yingzi Ming, Wei Zhang, Gan Zhou	7
10	In vivo pharmacodynamic and pharmacokinetic effects of metformin mediated by the gut microbiota in rats 2019 ·Life Sciences ·(unknown), Man‐Yun Chen, Yongchao Gao, (unknown), Mouze Liu, Wei Zhang, Weihua Huang	26
11	Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation 2018 ·Current Drug Metabolism ·Yu Meng, Mouze Liu, Wei Zhang, Yingzi Ming	119
12	European versus Asian differences for the associations between paraoxonase‐1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus 2018 ·Journal of Cellular and Molecular Medicine ·Jian‐Quan Luo, Huan Ren, Mouze Liu, Pingfei Fang, Daxiong Xiang	38
13	IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients 2017 ·Acta Pharmacologica Sinica ·Mouze Liu, (unknown), Yueli Zhang, HU Yong-fang, Fazhong He, Jian‐Quan Luo, Zhiying Luo, Xiaoping Chen, Zhaoqian Liu, Hong‐Hao Zhou, Mingjie Shao, Yingzi Ming, Hua‐Wen Xin, Wei Zhang	24
14	Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering Treatment 2016 ·EBioMedicine ·Fazhong He, Mouze Liu, (unknown), Guojing Liu, Zhenmin Wang, Rong Liu, Jian‐Quan Luo, Jie Tang, Xingyu Wang, (unknown), Honghao Zhou, Xiaoping Chen, Zhaoqian Liu, Wei Zhang	13
15	[Epigenetic research progress of anti-tumor drugs]. 2013 ·PubMed ·Mouze Liu, Fazhong He, Wei Zhang	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact